Introduction
The Ras signaling protein has a major role in regulating growth, dierentiation, and oncogenesis (reviewed in Marais and Marshall, 1996; Pritchard and McMahon, 1997) . One of the main eectors for Ras is the Raf-1 serine/threonine kinase which heads a MAP kinase cascade. While the mechanism for the activation of Ras has been largely elucidated, the subsequent mechanisms of activation of Raf-1 are complex and incompletely understood.
In the MAP kinase pathway (reviewed in Marais and Marshall, 1996; Pritchard and McMahon, 1997) activation of tyrosine kinase receptors leads to colocalization of Sos1 and Ras (Buday and Downward, 1993) . Sos1 catalyses the production of active RasGTP from inactive RasGDP and activated Ras recruits Raf-1 to the plasma membrane from the cytosol. At the membrane Raf-1 is activated partially by interactions with Ras (Drugan et al., 1996; Mineo et al., 1997; Roy et al., 1997; Stokoe and McCormick, 1997) but also by other mechanisms that require phosphorylation of tyrosine (Fabian et al., 1993; Dent et al., 1995a; Marais et al., 1995; Jelinek et al., 1996) and the presence of certain serine and threonine residues which may be phosphorylated (Fabian et al., 1993; Dent et al., 1995a; Diaz et al., 1997) . Candidate kinases that may regulate Raf-1 activity at the plasma membrane include the scaold protein KSR (Yao et al., 1995; Therrien et al., 1996; Zhang et al., 1997) , protein kinase C (Kolch et al., 1993) , cAMP-dependent protein kinase or protein kinase A (Kikuchi and Williams, 1996) and AMP-activated protein kinase (Sprenkle et al., 1997) . Activated Raf-1 phosphorylates and activates MEK1 and MEK2 which in turn phosphorylate and activate ERK1 and ERK2 (Marais and Marshall, 1996; Pritchard and McMahon, 1997) .
Recent studies have shown that the Raf Cysteine Rich Domain (CRD) is critical for Raf-1 activation. The RafCRD comprises residues 139 to 184 and contains a zinc ®nger (Mott et al., 1996) . Mutation of the CRD zinc ®nger partially abrogates Rasdependent activation of Raf-1 but does not compromise Ras-dependent membrane recruitment (Dent et al., 1995b; Drugan et al., 1996; Luo et al., 1997; Roy et al., 1997) . These data indicate that an intact zinc ®nger is required for some aspect of Raf-1 activation that occurs at the plasma membrane. In addition to Ras, two other CRD ligands have been identi®ed: 14-3-3 proteins, which bind to two phosphoserine-containing sites on Raf-1 (Muslin et al., 1996) as well as to the RafCRD (Michaud et al., 1995; Clark et al., 1997) , and phosphatidylserine (PS), a plasma membrane inner lea¯et phospholipid (Ghosh et al., 1994) that can activate Raf-1 in vitro (Force et al., 1994) .
14-3-3 proteins are a family of adaptor molecules which bind to many signalling molecules (Aitkin, 1996) . The eect of 14-3-3 proteins on the kinase activity of Raf-1 is contentious, since in vitro they have been reported to either have no eect on Raf-1 kinase activity (Fu et al., 1994; Michaud et al., 1995; Suen et al., 1995) or to activate Raf-1 (Fantl et al., 1994; Freed et al., 1994; Irie et al., 1994; Li et al., 1995) . Genetic studies have identi®ed dominant negative 14-3-3 mutants that can inhibit signalling downstream of Ras and Raf-1 (Chang and Rubin, 1997) and have con®rmed that 14-3-3 proteins are required for Rasmediated Raf-1 activation (Kockel et al., 1997) . In contrast, other data suggest that 14-3-3 may inhibit Raf-1 activation. For example, a Raf-1 mutation that abrogates binding of 14-3-3 to the isolated CRD domain in vitro renders Raf-1 transforming in vivo (Clark et al., 1997) , and an S259A mutation that abrogates binding of 14-3-3 to the N-terminus of Raf-1 (Rommel et al., 1996) increases Raf-1 kinase activity (Rommel et al., 1997) . In a recent study, we have reconciled some of these disparate observations. We showed that Raf-1 must be complexed with 14-3-3 for ecient Ras mediated plasma membrane recruitment and activation, but that 14-3-3 is completely displaced when Raf-1 binds to the plasma membrane (Roy et al., 1998) . In addition 14-3-3 has a subsequent role in removing Raf-1 from the plasma membrane and recycling it back to the cytosol (Roy et al., 1998) . Although, activated Ras can displace 14-3-3 from the Raf-1 N-terminus in vitro (Rommel et al., 1996) , the mechanism for the complete removal of 14-3-3 that occurs when Raf-1 is recruited to the plasma membrane by Ras, or targeted to the plasma membrane using the Ras localization motifs is presently unknown.
Here, we have investigated the interaction of 14-3-3 and PS with the RafCRD in an attempt to determine the relative contributions that each makes to the activation of Raf-1. We show that the zinc ®nger of the RafCRD is required to stabilize the Raf-14-3-3 interaction and that PS can displace 14-3-3 from Raf-1 in vitro. The displacement of 14-3-3 by PS is calcium dependent and results in enhanced Raf-1 kinase activity. In contrast, removal of 14-3-3 from Raf-1 by peptides homologous to the 14-3-3 binding sites on Raf-1 signi®cantly reduces Raf-1 kinase activity. The removal of 14-3-3 from Raf-1 by PS in vitro suggests a mechanism for the removal of 14-3-3 from Raf-1 at the plasma membrane in vivo.
Results
The CRD is required for a stable interaction of 14-3-3 with Raf-1
The isolated RafCRD binds to 14-3-3 in vitro (Clark et al., 1997) and C165S,C168S mutations that disrupt the zinc ®nger within the RafCRD (RafCC/SS), have been reported to abrogate all binding of 14-3-3 to full-length Raf-1 in vitro (Michaud et al., 1995) . However, when anti-Flag immunoprecipitates prepared from the NP-40 soluble fraction of COS cells expressing FlagRafCC/SS were immunoblotted for 14-3-3 we found a substantial amount of 14-3-3 was present, comparable to the amount of 14-3-3 in immunoprecipitates prepared from cells expressing wild type FlagRaf (Figure 1 ). When the Flag immunoprecipitates were incubated at 308C for 15 min and then re-washed, all of the 14-3-3 was removed from RafCC/SS, whereas there was minimal loss of 14-3-3 from wild type Raf-1 (Figure 1 ). This result indicates that RafCC/SS does complex with 14-3-3, but because the complex is disrupted by mild temperatures the interaction must be much weaker than with wild type Raf. One interpretation of this data is the interaction of the CRD with 14-3-3 stabilizes the Raf/14-3-3 complex.
Phosphatidylserine displaces 14-3-3 from Raf-1 and stimulates kinase activity
Since both PS and 14-3-3 bind to the RafCRD (Ghosh et al., 1994; Clark et al., 1997) , we investigated to what extent the binding of 14-3-3 to Raf-1 was in¯uenced by PS. A mixture of calcium, diacylglycerol and PS has been shown previously to activate Raf-1 in vitro (Force et al., 1994) . However, for this study we prepared PS in a buer containing calcium but no diacylglycerol to address the speci®c contribution of PS/Ca. Anti-Flag immunoprecipitates prepared from cells expressing wild type Raf-1 were incubated at 308C with increasing amounts of PS/Ca and immunoblotted for 14-3-3. Under these assay conditions a progressive loss of 14-3-3 was observed, with complete removal of 14-3-3 occurring at 0.63 mM PS (Figure 2a) . PS/Ca also promoted the loss of 14-3-3 from constitutively active RafDD in a similar fashion to that observed for wild type Raf-1 (Figure 2a) . Thus the displacement of 14-3-3 by PS/Ca is unaected by the activation state of Raf-1. No 14-3-3 remains bound to RafCC/SS after incubation at 308C in wash buer alone (Figure 1 ) and this loss of 14-3-3 from RafCC/SS was unaected by the presence of PS/Ca (data not shown).
The eect of PS/Ca on the basal kinase activity of immunoprecipitated Raf-1 was then evaluated. FlagRaf immunoprecipitates were incubated for 15 min at 308C in the presence of increasing concentrations of PS/Ca and kinase activity measured in a coupled MEK/ERK assay. Figure 2b shows that PS/Ca increased the basal kinase activity of wild type Raf-1 with maximum stimulation occurring at 0.6 mM PS (Figure 2b ). Clearly, there is a good correlation between the dose reponse curves for PS/Ca mediated 14-3-3 displacement and PS/Ca stimulation of Raf-1 kinase activity, although at concentrations of PS greater than 0.6 mM, there was some inhibition of basal kinase activity. Identical experiments were then carried out with constitutively active RafDD. Figure 2b shows that the basal kinase activity of immunoprecipitated RafDD, which is sixfold greater than the basal kinase activity of wild type Raf-1, was not signi®cantly aected by incubation with PS/Ca. Similarly, immu- Figure 1 Mutation of the RafCRD destabilizes the interaction of Raf-1 with 14-3-3. Anti-Flag immunoprecipitates were prepared from cells expressing wild type FlagRaf (WT), FlagRafCC/SS (CCSS) or transfected with empty vector (C). The immunoprecipitates were washed once with buer B and then incubated on ice for 15 min and washed twice with buer B (I), or incubated at 308C for 15 min and washed twice with buer B (30). The samples were then resolved by SDS ± PAGE and immunoblotted with anti-14-3-3 and anti-Raf-1 antibodies as described in Materials and methods. 14-3-3 remains complexed to wild type Raf-1 and RafCCSS when all washes are performed at 08C. During an extended 308C wash 14-3-3 remains complexed with wild type Raf-1 but not with RafCCSS noprecipitated RafCC/SS which was a basal kinase activity approximately 15% that of wild type Raf-1 was unaected by incubation with PS/Ca ( Figure 2b ).
We next examined whether similar concentrations of phospholipids other than PS would have the same eect on Raf-1. Figure 3 shows that incubation of wild type Raf-1 with phosphatidylcholine (PC), phosphatidic acid (PA), or phosphatidylinositol (PI) at concentrations of 0.5 or 1 mM, either with or without calcium, neither stimulated Raf-1 activity nor displaced 14-3-3. Indeed, PC, PA and PI all inhibited Raf-1 basal kinase activity. Interestingly neither PS alone, nor Ca alone displaced 14-3-3 or stimulated Raf-1 basal kinase activity (Figure 3) .
Although the displacement of 14-3-3 and activation of Raf-1 by PS/Ca may be unrelated, our favoured interpretation is that both eects are a consequence of PS/Ca binding to the CRD. We conclude that while 14-3-3 has three binding sites on Raf-1, the interaction of 14-3-3 with the CRD is critical to the stability of the Raf/14-3-3 complex. If the CRD/14-3-3 interaction is disturbed, either by mutations in the CRD or through the binding of another CRD ligand, PS/Ca, then the Raf/14-3-3 complex is destabilized and 14-3-3 is displaced. The displacement of 14-3-3 from wild type Raf-1 catalyzed by PS/Ca is accompanied by a stimulation of basal kinase activity: a response that requires an intact Raf zinc ®nger.
Raf phoshopeptides displace 14-3-3 from Raf but with varying eects on basal kinase activity
In the previous sections we investigated the eect of displacing 14-3-3 from Raf-1 by mutating the CRD or by incubating with PS/Ca. In addition to the CRD, two other 14-3-3 binding sites have been identi®ed on Raf-1 which comprise residues 254 ± 261 and 616 ± 623. Within each of these sites is a serine residue, S259 and S621 respectively, that must be phosphorylated for 14-3-3 to bind (Muslin et al., 1996) . Phosphoserine containing peptides corresponding to these Raf-1 sequences competitively displace 14-3-3 from Raf-1, whereas non-phosphorylated peptides do not (Muslin et al., 1996) . We therefore compared the eects of removing 14-3-3 from Raf-1 using phosphoserine peptides with removal of 14-3-3 using PS/Ca.
Two peptides, corresponding to the 14-3-3 binding site at S621, with and without phosphoserine were synthesized and incubated with FlagRaf immunoprecipitates. The phosphoserine-containing peptide (pS- Figure 2 Phosphatidylserine displaces 14-3-3 from wild type Raf-1 and RafDD but only stimulates the basal kinase activity of wild type Raf-1. (a) Anti-Flag immunoprecipitates were prepared from cells expressing wild type Raf-1 (upper panel), or RafDD (lower panel). (RafDD is a constitutively active Raf-1 protein containing the mutations Y340D, Y341D). After washing once in buer B and twice in buer D, immunoprecipitates were incubated at 308C for 15 min with PS/Ca at PS concentrations of 0, 0.25, 0.40, 0.63, 0.80 or 1.0 mM. All samples were then rewashed in buer D and immunoblotted for Raf-1 and 14-3-3 as described in Materials and methods. The ®gure shows a representative experiment that was repeated three times with similar results. (b) Anti-Flag immunoprecipitates prepared from cells expressing wild type Raf-1 RafCC/SS or RafDD were washed as described in Panel A and incubated at 308C for 15 min with increasing concentrations of PS/Ca (in the range 0 ± 1.0 mM). The immunoprecipitates were then rewashed (twice in buer D and once in buer C) and assayed for Raf-1 kinase activity using a coupled MEK ± ERK assay as described in Materials and methods. All kinase activities (mean +s.e.mean, n=3 ± 6) are given relative to the control sample containing wild type Raf-1 (=1) that was incubated without PS/Ca (0 mM). The results have been pooled from three experiments. Wild type Raf-1 is maximally stimulated at 0.5 mM PS/Ca whereas RafDD is not signi®cantly aected. Although the kinase activity of RafCCSS is reduced to 15% of wild type values it is readily measurable and showed no signi®cant stimulation by PS/Ca Raf621) removed 14-3-3 from wild type Raf-1 and RafDD with similar dose response curves: the concentration of pS/Raf621 required to remove 50% of 14-3-3 from both wild type Raf-1 and RafDD being approximately 10 mM (Figure 4a ). The control Raf621 peptide did not cause any release of 14-3-3 from wild type Raf-1 or RafDD at concentrations up to 1 mM (Figure 4a and data not shown) . Coincident with the removal of 14-3-3 from wild type Raf-1 by peptide pSRaf621 there was a progressive decrease in basal kinase activity (Figure 4b ). This loss of kinase activity could not be recovered by subsequent incubation with 0.6 mM PS/Ca (data not shown). In contrast, the kinase activity of RafDD was not aected by concentrations of pS-Raf621 as high as 300 mM, considerably greater than the peptide concentration required to completely remove all 14-3-3 from RafDD (Figure 4b) . We conclude that 14-3-3 is required to maintain the basal kinase activity of wild type Raf-1, but not RafDD, and that the removal of 14-3-3 from wild type Raf-1 by competing peptide diers signi®cantly from the removal of 14-3-3 by PS/Ca.
While this manuscript was in preparation. Avruch and coworkers (Tzivion et al., 1998) showed that the removal of 14-3-3 from wild type Raf-1 by peptide pSRaf621 results in almost complete loss of basal kinase activity, consistent with the data shown in Figure 4b . However, they also reported that 14-3-3 is required to maintain the activity of activated Raf, a result that is clearly at odds with the data presented in Figure 4b . A major dierence in the methodology used by Tzivion et al. (1998) is that in their study the pS-Raf621 peptide was added to whole cell lysates from which Raf-1 was subsequently anity puri®ed. We therefore investigated whether this could account for our quite dierent results. RafDD cytosol was supplemented with pSRaf621 to a ®nal concentration of 300 mM, incubated at 308C for 15 min and then immunoprecipitated. In parallel an equivalent aliquot of RafDD cytosol was ®rst immunoprecipitated and then incubated with 300 mM pS-Raf621 to remove 14-3-3 (as described in Figure 4) ; Raf-1 kinase activity was then assayed. Figure 5a shows that both assay conditions remove all detectable 14-3-3 from RafDD, but that RafDD Figure 3 The displacement of 14-3-3 and activation of Raf-1 by phosphatidylserine is calcium dependent. Wild type Raf-1 was immunoprecipitated from 12 10 cm dishes of transfected COS cells using anti-Flag sepharose. After washing twice in buer B and once in buer D the sepharose beads were divided into 18 aliquots and incubated for 15 min at 308C with buer D containing 0.5 or 1.0 mM phosphatidylserine (PS), phosphatidylcholine (PC), phosphatidic acid (PA) or phosphatidylinositol (PI), either with (+) or without calcium (Ca). Control incubations in buer D with no additions (®rst lane) and buer D with calcium alone (second lane) were also performed. After the 15 min incubation all samples were washed once with buer C and assayed for Raf-1 kinase activity. The beads were then washed twice in buer B, once in buer C and immunoblotted for Raf-1 and 14-3-3. Kinase results (mean +s.e.mean, n=3) are expressed relative to the control incubation in buer D alone (=1). An identical set of experiments was also carried out with RafDD: no phospholipid mix signi®cantly aected RafDD kinase activity and only PS/Ca displaced 14-3-3 (data not shown) incubated with pS-Raf621 peptide prior to immunoprecipitation is devoid of kinase activity, in agreement with the report of Tzivion et al. (1998) , whereas RafDD that is immunoprecipitated before incubation with the pS-Raf621 peptide retains kinase activity. Thus, 14-3-3 is required to maintain the kinase activity of activated Raf-1 that is in a soluble complex, but 14-3-3 is not required to maintain the kinase activity of activated Raf-1 once it has been removed from solution onto an insoluble matrix.
Discussion
The initial event in Raf-1 activation is recruitment of the Raf/14-3-3 complex from the cytosol to the plasma membrane (Leevers et al., 1994; Stokoe et al., 1994; Wartmann and Davis, 1994) . Raf-1 is normally recruited to the plasma membrane by RasGTP, but RafCAAX which is targeted to the plasma membrane independently of Ras is also activated. In both circumstances plasma membrane recruitment is accompanied by complete displacement of 14-3-3 from Raf-1 (Roy et al., 1998) . Therefore, although Ras can displace 14-3-3 from the Raf-1 N-terminus in vitro (Rommel et al., 1996) there must be a Ras independent mechanism for removal of 14-3-3 at the plasma membrane. There are three sites on Raf-1 that interact with 14-3-3, the CRD and two phosphoserine binding sites¯anking serine residues 259 and 621. Since the RafCRD has also been mapped as a binding site for PS, a phospholipid that is enriched in the inner lea¯et of the plasma membrane, we investigated whether the binding of PS to the RafCRD would be sucient to remove 14-3-3 from Raf-1.
The results presented here demonstrate that incubation of Raf-1 with PS, in vitro, completely displaces 14-3-3. Moreover, the PS induced loss of 14-3-3 from wild type Raf-1 is accompanied by a threefold increase in Raf-1 kinase activity. In contrast, when 14-3-3 is removed from Raf-1 using phosphoserine peptides, there is a complete loss of Raf-1 basal kinase activity, which is not recovered by subsequent incubation with PS. The phosphoserine peptides are homologous to Raf-1 sequences distant from the RafCRD so it is unlikely that the peptides directly interfere with PS binding by a competitive mechanism. Rather, removal of 14-3-3 by the peptides probably alters or destabilizes Raf-1 so that PS can either no longer bind to the CRD or cannot activate Raf-1.
The displacement of 14-3-3 and activation of Raf-1 by PS/Ca is clearly not a non-speci®c`detergent-like' eect, because we observed remarkable selectivity for PS/Ca over other phospholipid/Ca combinations. Indeed, all of the other lipids we tested weakly inhibited Raf-1 activity and failed to displace 14-3-3. Figure 4 Peptide pS-Raf621 removes 14-3-3 from Raf-1 and RafDD and abrogates the kinase activity of wild type Raf-1. (a) Peptides pS-Raf621 and Raf621 homologous to Raf-1 residues 613 ± 627: LPKINRSApSEPSLHR and LPKINRSASEPSLHR respectively (where pS is phosphoserine) were synthesized and analysed by HPLC before use. Anti-Flag immunoprecipitates were prepared from cells expressing wild type Raf-1 or RafDD. After washing three times in buer B, samples were incubated at 308C for 15 min with increasing concentrations of peptide pS-Raf621 (&) or Raf621 (^) and extensively washed as described in Materials and methods. The samples were then resolved by SDS ± PAGE and quantitatively immunoblotted for 14-3-3. The graphs show the amount of 14-3-3 bound relative to control sample (100%) that was incubated without peptide. Peptide Raf621 has no eect on 14-3-3 binding to Raf-1 or RafDD at any of the concentrations tested, whereas 200 mM peptide pS-Raf621 completely displaces 14-3-3 from Raf-1 and RafDD. The results shown are pooled from a series of four experiments. (b) Anti-Flag immunoprecipitates prepared from cells expressing wild type Raf-1 or RafDD were washed and incubated at 308C for 15 min with various concentrations of peptide pS-Raf621 as described in panel A. The immunoprecipitates were then assayed for Raf-1 kinase activity using a coupled MEK ± ERK assay. All kinase activities (mean+s.e. mean, n=6) are given relative to a control sample (100%) that was incubated without peptide. The results have been pooled from three experiments
The eect of PS/Ca is also quite distinct from the two documented eects that detergents have on Raf-1: RIPA buer displaces 14-3-3 from Raf-1 without aecting kinase activity (Michaud et al., 1995) , whereas Empigen-BB displaces 14-3-3 and inactivates Raf-1 (Thorson et al., 1998) . Clearly the eect of PS/ Ca mimics neither of these.
We showed previously that 14-3-3 needs to be complexed with Raf-1 in order for Raf-1 to be recruited to the P100 fraction and activated by Ras (Roy et al., 1998) but did not address whether 14-3-3 was required to maintain the activity of Raf-1 following activation; although this seemed unlikely since 14-3-3 is displaced from Raf-1 at the plasma membrane. The new data presented here directly addresses the issue of 14-3-3 and activated Raf-1: 14-3-3 is not absolutely required to keep Raf-1 in the activated state, but exactly how 14-3-3 is displaced is critically important. PS/Ca removes 14-3-3, moderately activates kinase activity and ensures that Raf-1 is competent for activation by other membrane factors. Conversely, removal of 14-3-3 in the absence of the CRD ligand PS severely compromises Raf-1 activation, both by reducing basal kinase activity (this study) and impairing Raf-1 membrane recruitment (Roy et al., 1998) .
A further demonstration of how cellular location in¯uences the eect of displacing 14-3-3 is also highlighted by results with activated Raf-1. The data presented in Figures 4 and 5 show that, if activated RafDD is removed from solution onto an insoluble matrix before 14-3-3 is displaced then kinase activity is not compromised. However, if activated Raf-1 is present as a soluble complex then 14-3-3 is absolutely required to maintain kinase activity (Tzivion et al., 1998) . This is consistent with the observation made in intact cells, that Raf-1 which has been recruited from the cytosol to the plasma membrane and activated is not complexed with 14-3-3 (Roy et al., 1998) . Taking these studies together, we conclude that 14-3-3 is not required to maintain the integrity of the Raf-1 kinase domain, nor to maintain the activation state if Raf-1 remains associated with the plasma membrane and thus insoluble. Although this is the favoured reconciliation of our data and those of Tzivion et al. (1998) , we cannot formally exclude the possibility that the dierent expression systems and mode of activating Raf in the two studies also contributed to the contrasting results.
How does the interaction of PS/Ca with Raf-1 result in loss of 14-3-3? Two lines of evidence implicate an interaction of PS/Ca with the RafCRD. First, disruption of the zinc ®nger within the CRD resulted in complete loss of 14-3-3 from Raf-1 at 308C but did not compromise 14-3-3/Raf binding at 08C. This result suggests that the Raf-1 zinc ®nger is not absolutely required for 14-3-3 binding but may be required to stabilize the Raf/14-3-3 interaction. Secondly, the incubation of PS/Ca with Raf-1 resulted in complete displacement of 14-3-3. It is therefore tempting to speculate that the plasma membrane recruitment of Raf-1 is accompanied by displacement of 14-3-3 because PS/Ca binds to the RafCRD and disrupts the CRD/14-3-3 interaction, which has the eect of destabilizing the whole Raf/14-3-3 complex.
The low basal kinase activity of RafCC/SS was not stimulated by PS/Ca. Thus the zinc ®nger either comprises part of the PS/Ca binding site within the CRD, or the CCSS mutations completely disorder the CRD. Inspection of the NMR structure of the RafCRD (Mott et al., 1996) suggests that a likely binding site for PS includes Raf-1 residues 128 ± 147, which form a hydrophobic channel. This is consistent with the data of Ghosh et al., 1994; 1996 who showed that two Raf-1 fragments, each containing the region 128 ± 147 of the RafCRD bound PS equally well. It is also worth noting that residues 143 and 144 probably comprise part of the 14-3-3 binding site (Clark et al., 1997) and that overlapping binding sites for PS/Ca and 14-3-3 would oer a simple competitive mechanism for the displacement of 14-3-3 by PS/Ca. We also observed that the activation of Raf-1 by PS was calcium dependent, thus as with protein kinase C (Newton, 1995) , calcium ions seem to be required for the binding of PS to the RafCRD.
Taking our results together with our published data, we propose that activated Ras recruits Raf-1 to the plasma membrane where an interaction between the RafCRD and the membrane lipid PS destabilizes the Raf/14-3-3 complex leading to loss of 14-3-3. Removal of 14-3-3 by PS at the plasma membrane weakly stimulates Raf-1 kinase activity, but, importantly, maintains Raf-1 in a conformation that is competent for further activation. Subsequent activating events may include tyrosine phosphorylation, dephosphoryla- Figure 5 Soluble RafDD requires 14-3-3 to maintain kinase activity. A whole cell lysate of COS cells expressing RafDD was prepared in buer B as described (Materials and methods). Aliquots of the lysate were immunoprecipitated (IP) for 60 min at 48C using anti-Flag sepharose, washed twice in buer B and incubated at 308C for 15 min with 300 mM pS-Raf621 (lane 1) or Raf621 peptide (lane 2). The immunoprecipitates were then washed twice with buer B, once with buer C and assayed for Raf-1 kinase activity. Equivalent aliquots were incubated at 308C for 15 min with 300 mM pS-Raf621 (lane 3) or Raf621 peptide (lane 4) and then immunoprecipitated for 60 min at 48C using anti-Flag sepharose. The immunoprecipitates were washed four times with buer B and once with buer C and assayed for Raf-1 kinase activity. Both sets of Flag immunoprecipitates were Western blotted (WB) for Raf-1 and 14-3-3. RafDD that is incubated with peptide pS-Raf621 prior to capture on to the sepharose beads is devoid of kinase activity, whereas RafDD that is immobilized onto sepharose beads prior to incubation with peptide pS-Raf621 retains kinase activity. The 14-3-3 immunoblots (and Figure 4) show that both assay conditions remove all detectable 14-3-3 from RafDD tion of S621 and S259 and an interaction of the CRD with Ras. In turn, Raf-1 deactivation likely involves rephosphorylation of S621 and S259 as a prelude to the rebinding of 14-3-3 and the extraction of Raf-1 from the membrane to cytosol. This model is under further investigation.
Materials and methods

Materials and buers
Bovine brain phosphatidylserine, phosphatidylcholine, phosphatidic acid, phosphatidylinositol and myelin basic protein (MBP) were obtained from Sigma. M2 (Flag) anity beads were purchased from Kodak. Buer B was 50 mM TrisC1 pH 7.4, 75 mM NaC1, 5 mM MgC1 2 , 5 mM EGTA, 1% NP40, 25 mM NaF, 0.1 mM NaVO 4 , 1 mM DTT. Buer C was identical to Buer B but without the NP40. Buer D was 10 mM TrisC1 pH 7.4, 1 mM EDTA, 4 mM EGTA, 25 mM NaF, 0.1 mM NaVO 4 and 1 mM DTT. The buers were prepared fresh and kept on ice until use. EXV plasmids containing inserts coding for FlagRaf, FlagRafCC/SS and FlagRafDD were as described (Roy et al., 1997) . Antibodies, Raf-1(C-20) and 14-3-3 (K-19) were obtained from Santa Cruz. Peptides, synthesized by Chiron Mimotopes, were analysed by HPLC, dried down under vacuum, and resuspended to 5 mM in 10 mM TrisC1, pH 7.5 and stored in aliquots at 7708C.
Immunoprecipitations
COS1 cells transfected according to the method described in (Huang et al., 1993) were harvested into phosphate buered saline (PBS) and stored at 7708C. Cell pellets were thawed on ice, resuspended in buer B, brie¯y vortexed and spun at 13 000 g for 5 min at 48C. The supernatant was added to anti-Flag M2 anity beads so that 25 ml of bead slurry was used per 10 cm diameter plate seeded with 3610 6 electroporated COS cells. The beads were gently rotated for 1 h at 48C and washed twice in buer B and twice in the required assay buer.
Raf assays
Raf-1 immunoprecipitated from approximately one quarter of a 10 cm plate seeded with 3610 6 electroporated COS1 cells was used per assay. Immunoprecipitated Raf-1 was treated according to the text and then washed as described for that particular experiment. The kinase assays were then performed in duplicate as described (Stokoe et al., 1994; Roy et al., 1997) . Brie¯y, 3.6 ml of a mixture of MEK (0.2 mg), ERK (1 mg), 40 mM MgC1 2 and 5 mM ATP in buer C was added and the beads vortexed at 308C for 20 min on a Eppendorf Thermomixer. Forty ml of buer C was added and the beads mixed by tapping on the side of the tube. The beads were then brie¯y spun and 10 ml of supernatant was removed for the rest of the kinase assay. SDS ± PAGE loading buer (40 ml) was added to the remaining beads, which were boiled, stored at 7708C and the samples later analysed for Raf-1 content by Western blotting and chemiluminescence. A 15 ml aliquot of mix containing [ 32 P]ATP (1200 c.p.m./pmol) MBP (16 mg)/MgC1 2 (50 mM)/ ATP (0.5 mM) was added to the 10 ml of supernatant and the mixture vortexed at 308C for 10 min. The reaction was terminated by immediately placing on ice. Ten ml of a 56 SDS ± PAGE loading buer solution was added and the mixture loaded onto a 15% SDS ± PAGE gel. Phosphorylation of MBP was determined by analysis of the amount of 32 P incorporated into the MBP band on the SDS ± PAGE gel which was scanned into a Bio-Rad molecular Imager.
The data analysis was performed after subtraction of the background due to extracts of cells electroporated with the EXV vector plasmid without an insert (`EXV alone'). Thè EXV alone' immunoprecipitate controls were treated exactly the same as every other tube in the experiment. The data was then normalized for Raf-1 content from the results of the chemiluminescence of the Western blots.
Peptide competition assays
Raf-1 was immunoprecipitated from lysates prepared from approximately 1.5610 6 electroporated COS1 cells as described above. The immunoprecipitates were washed three times in buer B and incubated with the peptide at the speci®ed concentration. The beads were then washed three times in buer C. Thirty ml of SDS ± PAGE loading buer was added and the samples boiled for 10 min. The samples were then spun down and the supernatant loaded on to SDS ± PAGE gels. The gels were then analysed for Raf-1 and 14-3-3 content by Western blotting and chemiluminescence.
Incubation of Raf-1 with phospholipids
Phospholipids stored in 10 ml aliquots was dried on ice under nitrogen and resuspended to 1.3 mM by sonication in buer D (with or without 10 mM CaC1 2 ) in a Branson sonicating water bath at 48C for 20 min. For kinase assays, the phospholipid/Ca mix was added to immunoprecipitates that had been washed (once in buer B and twice in buer D) and then incubated for the speci®ed time with vortexing at 308C. The samples were then washed twice with buer D and once with buer C and treated as described for the kinase assays. For the determinations of 14-3-3 bound after phospholipid treatment, the samples were washed three times with buer D and analysed for Raf-1 and 14-3-3 content as described for the peptide competition assays.
